Inventor · disambiguated record
Birgitte P.S. Jacky
Also filed as: JACKY BIRGITTE P · JACKY BIRGITTE P S
16 granted patents·20 pending applications·72 citations·filing 2009–2022
93Inventor score
Top patents by PatentIndex Score
36 records- 0195US8455247B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Jun 4, 2013·10 cites·5 claims
- 0295US8455213B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Jun 4, 2013·14 cites·5 claims
- 0395US8361789B2Cells useful for immuno-based Botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2010·Granted Jan 29, 2013·13 cites·5 claims
- 0492US8507271B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Aug 13, 2013·6 cites·5 claims
- 0592US8501469B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Aug 6, 2013·6 cites·5 claims
- 0689US8691566B1Cells useful for immuno-based botulinum toxin serotype a activity assaysZHU HONG·Filed 2011·Granted Apr 8, 2014·4 cites·5 claims
- 0789US8455248B2Cells useful for immuno-based Botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Jun 4, 2013·4 cites·5 claims
- 0888US8476068B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Jul 2, 2013·3 cites·5 claims
- 0986US9625447B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Apr 18, 2017·2 cites·5 claims
- 1086US2023323290A1Cells useful for immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2022·Application pending·0 cites
- 1184US8497081B2Botulinum toxin screening assaysFERNANDEZ-SALAS ESTER·Filed 2009·Granted Jul 30, 2013·9 cites·5 claims
- 1281US8476069B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Jul 2, 2013·1 cites·5 claims
- 1379US2021163887A1Cells useful for immuno-based botulinum toxin serotype a activity assaysALLERGAN INC·Filed 2021·Application pending·0 cites
- 1473US2023302103A1Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melaninALLERGAN INC·Filed 2022·Application pending·0 cites
- 1571US10912823B2Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melaninALLERGAN INC·Filed 2018·Granted Feb 9, 2021·0 cites·20 claims
- 1671US2017218334A1Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity AssaysALLERGAN INC·Filed 2017·Application pending·0 cites
- 1767US8663983B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Mar 4, 2014·0 cites·5 claims
- 1867US8663982B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Mar 4, 2014·0 cites·5 claims
- 1967US8603812B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Dec 10, 2013·0 cites·5 claims
- 2065US8603813B2Cells useful for immuno-based botulinum toxin serotype A activity assaysZHU HONG·Filed 2011·Granted Dec 10, 2013·0 cites·5 claims
- 2165US2021162027A1Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melaninALLERGAN INC·Filed 2021·Application pending·0 cites
- 2257US2023332126A1Botulinum Neurotoxin Proteins and Methods to Engineer and Generate SameUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2352US2011070186A1Methods of Treating Cancer Using Growth Factor Retargeted EndopeptidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 2449US2013224178A1Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted EndopepidasesALLERGAN INC·Filed 2013·Application pending·0 cites
- 2548US2013195838A1Methods of Treating Cancer Using Growth Factor Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 2648US2013230502A1Methods of treating cancer using opiod retargeted endopepidasesALLERGAN INC·Filed 2012·Application pending·0 cites
- 2743US2011070212A1Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted EndopeptidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 2843US2011064713A1Methods of Treating Cancer Using Opioid Retargeted EndopepidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 2943US2011110911A1Methods of Treating Cancer Using Tachykinin Retargeted EndopepidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 3042US2012207742A1Treatments Using PSMA Ligand EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 3140US2012207743A1Inhibiting Aberrant Blood Vessel Formation Using Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 3240US2012207733A1Treating a Disease of Hyperproliferation Using Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 3340US2012207704A1Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted EndopeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 3440US2012207734A1Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted EndpeptidasesJACKY BIRGITTE P S·Filed 2012·Application pending·0 cites
- 3535US2011070215A1Methods of treating cancer using neurotrophin retargeted endopeptidasesALLERGAN INC·Filed 2010·Application pending·0 cites
- 3635US2011070211A1Methods of Treating Cancer Using Galanin Retargeted EndopepidasesALLERGAN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Birgitte P.S. Jacky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →